A Multicenter, Randomized, Double-blind, Parallel-group, Evaluation of 12 Weeks of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children 6 to 17 Years of Age With Hypertension.

Trial Profile

A Multicenter, Randomized, Double-blind, Parallel-group, Evaluation of 12 Weeks of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children 6 to 17 Years of Age With Hypertension.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Feb 2017

At a glance

  • Drugs Valsartan (Primary) ; Enalapril
  • Indications Hypertension
  • Focus Registrational; Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 03 Jul 2012 Actual patient number of the extension trial (EudraCT2006-005408-14) changed from 250 to 300 as European Clinical Trials Database.
    • 03 Jul 2012 Actual patient number of the extension trial (EudraCT2006-005408-14) changed from 250 to 300 as European Clinical Trials Database.
    • 03 Jul 2012 Actual initiation date of the extension trial (EudraCT2006-005408-14) is 23 Apr 2007 as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top